Treatment of cancer by alteration of a cancer specific surface membrane epitope.
Since cancer is essentially a cell surface problem with loss of contact inhibition, effort might be directed to restoring such inhibition by interfering with activity of new determinants on the cancer cell surface associated with the contact inhibition loss.